RHHBY
Price
$53.34
Change
+$0.14 (+0.26%)
Updated
Jan 13 closing price
Capitalization
343.25B
14 days until earnings call
Intraday BUY SELL Signals
RHHVF
Price
$426.00
Change
-$0.80 (-0.19%)
Updated
Jan 13 closing price
Capitalization
343.25B
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RHHBY vs RHHVF

Header iconRHHBY vs RHHVF Comparison
Open Charts RHHBY vs RHHVFBanner chart's image
Roche Holding
Price$53.34
Change+$0.14 (+0.26%)
Volume$2.47M
Capitalization343.25B
Roche Holding
Price$426.00
Change-$0.80 (-0.19%)
Volume$6.27K
Capitalization343.25B
RHHBY vs RHHVF Comparison Chart in %
RHHBY
Daily Signal:
Gain/Loss:
RHHVF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RHHBY vs. RHHVF commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHBY is a Hold and RHHVF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (RHHBY: $53.96 vs. RHHVF: $422.65)
Brand notoriety: RHHBY and RHHVF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBY: 52% vs. RHHVF: 2%
Market capitalization -- RHHBY: $343.25B vs. RHHVF: $343.25B
RHHBY [@Pharmaceuticals: Major] is valued at $343.25B. RHHVF’s [@Pharmaceuticals: Major] market capitalization is $343.25B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $960.61B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $111.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBY’s FA Score shows that 2 FA rating(s) are green whileRHHVF’s FA Score has 2 green FA rating(s).

  • RHHBY’s FA Score: 2 green, 3 red.
  • RHHVF’s FA Score: 2 green, 3 red.
According to our system of comparison, RHHBY is a better buy in the long-term than RHHVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBY’s TA Score shows that 3 TA indicator(s) are bullish while RHHVF’s TA Score has 4 bullish TA indicator(s).

  • RHHBY’s TA Score: 3 bullish, 5 bearish.
  • RHHVF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RHHVF is a better buy in the short-term than RHHBY.

Price Growth

RHHBY (@Pharmaceuticals: Major) experienced а +1.66% price change this week, while RHHVF (@Pharmaceuticals: Major) price change was +0.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.96%. For the same industry, the average monthly price growth was +3.88%, and the average quarterly price growth was +16.25%.

Reported Earning Dates

RHHBY is expected to report earnings on Jan 29, 2026.

RHHVF is expected to report earnings on Jan 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+0.96% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($343B) and RHHVF($343B) have the same market capitalization . RHHBY (29.46) and RHHVF (28.84) have similar P/E ratio . RHHBY YTD gains are higher at: 3.432 vs. RHHVF (3.169). RHHBY (18B) and RHHVF (18B) have comparable annual earnings (EBITDA) . RHHBY (12B) and RHHVF (12B) have equal amount of cash in the bank . RHHBY (33B) and RHHVF (33B) have identical debt. RHHBY (63.5B) and RHHVF (63.5B) have equivalent revenues.
RHHBYRHHVFRHHBY / RHHVF
Capitalization343B343B100%
EBITDA18B18B100%
Gain YTD3.4323.169108%
P/E Ratio29.4628.84102%
Revenue63.5B63.5B100%
Total Cash12B12B100%
Total Debt33B33B100%
FUNDAMENTALS RATINGS
RHHBY vs RHHVF: Fundamental Ratings
RHHBY
RHHVF
OUTLOOK RATING
1..100
7118
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
5069
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
4242
P/E GROWTH RATING
1..100
1717
SEASONALITY SCORE
1..100
7565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (16) in the null industry is in the same range as RHHVF (16). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's Profit vs Risk Rating (50) in the null industry is in the same range as RHHVF (69). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's SMR Rating (99) in the null industry is in the same range as RHHVF (99). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's Price Growth Rating (42) in the null industry is in the same range as RHHVF (42). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

RHHBY's P/E Growth Rating (17) in the null industry is in the same range as RHHVF (17). This means that RHHBY’s stock grew similarly to RHHVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBYRHHVF
RSI
ODDS (%)
Bearish Trend 2 days ago
41%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 3 days ago
43%
Bullish Trend 2 days ago
56%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 8 days ago
53%
Bullish Trend 3 days ago
55%
Declines
ODDS (%)
Bearish Trend 10 days ago
46%
Bearish Trend 20 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
44%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
RHHBY
Daily Signal:
Gain/Loss:
RHHVF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMND2.440.28
+12.96%
Clearmind Medicine Inc.
RBBN2.890.08
+2.85%
Ribbon Communications
SILC15.350.26
+1.72%
Silicom Ltd
EMA47.980.19
+0.40%
Emera Inc
TLX7.45-0.10
-1.32%
Telix Pharmaceuticals Ltd.

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
+0.26%
RHHVF - RHHBY
65%
Loosely correlated
-0.19%
NVS - RHHBY
37%
Loosely correlated
-0.15%
JNJ - RHHBY
37%
Loosely correlated
+1.87%
RHHBF - RHHBY
32%
Poorly correlated
+0.12%
BMY - RHHBY
28%
Poorly correlated
+0.27%
More

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
-0.19%
RHHBY - RHHVF
65%
Loosely correlated
+0.26%
JNJ - RHHVF
31%
Poorly correlated
+1.87%
NVS - RHHVF
27%
Poorly correlated
-0.15%
AZN - RHHVF
26%
Poorly correlated
+0.94%
RHHBF - RHHVF
25%
Poorly correlated
+0.12%
More